News

AddToAny

Google+ Facebook Twitter Twitter

Early disease detection using DNA droplets

A group of scientists has developed a computational DNA droplet with the ability to recognise specific combinations of chemically synthesised microRNAs (miRNAs) that act as biomarkers of tumours.

Using these miRNAs as molecular input, the droplets can give a DNA logic computing output through physical DNA droplet phase separation.

Professor Masahiro Takinoue from Tokyo University of Technology said: “Even though biological systems regulate their functions by combining biosensing with molecular logical computation, no literature is available on integration of DNA droplet with molecular computing.”

Developing this DNA droplet required a series of experiments. First, they designed three Y-shaped DNA nanostructures called Y-motifs A, B, and C with three sticky ends to make A, B, and C DNA droplets.

The team used linker molecules to join the A droplet with B and C droplets. They evaluated the “AND” operation in the AB droplet mixture by introducing two input DNAs.

They then introduce breast cancer tumour markers, miRNA-1 and miRNA-2, to the AC droplet mixture as inputs for the AND operation. The AND operation was successful, implying that the computational DNA droplet identified the miRNAs.

bit.ly/3Q5IJnq

Image credit | iStock

 

Related Articles

The lesser horseshoe bat (Rhinolophus hipposideros)-Image Credit | istock-816193242

Bat swarming and immunity

Bats carry some of the deadliest zoonotic diseases that can infect both humans and animals, such as Ebola and COVID-19.

Pancreas or pancreatic cancer with organs and tumors or cancerous cells 3D rendering illustration with male bodyImage Credit | istock-1467893187

Fibroblast cells and pancreatic cancer growth

Older people may be at greater risk of developing pancreatic cancer and have poorer prognoses because of age-related changes in cells in the pancreas called fibroblasts, it is claimed.

brain tumour CREDIT_science photo library

Pores for thought

A team from Nottingham looks at intraoperative molecular diagnosis of brain tumours using nanopore sequencing.

CRISPR-Cas9 gene editing complex, illustration.Image credit - Science-Photo-Library-f0248864

Activating genes using CRISPR technology

There are over 7000 different rare genetic diseases, and often it can be a significant challenge and take a long time to receive a correct diagnosis.

Top